Private company
ALLIED HEALTHCARE PRODUCTS INC
ALLIED HEALTHCARE PRODUCTS INC is an American orthopedic company based in Saint Louis, incorporated in Delaware.2
Last updated Oct 21, 2026.
Overview
- IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies2
- HeadquartersSaint Louis, United States2
- Incorporated inDE4
- Business address1720 Sublette Ave, St Louis, Mo 631104
- Filer categoryNon-accelerated filer, Smaller reporting company4
- Legal formCorporation2
- LEI549300JCNCTXXAG8MR632
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O The Corporation Trust Company, 19801 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 8840622
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue75¢$24.5M
- Research and development1¢$260.4K
- Selling, general and admin22¢$7.1M
- Interest1¢$191.4K
- Income tax2¢$599.7K
Out of $27.0M in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.5M5 | $36.0M6 | $33.5M7 | $33.8M8 | $31.4M9 | $31.9M3 | $36.3M3 | $27.0M3 |
| Cost of revenue | $28.4M5 | $28.6M6 | $27.0M7 | $27.3M8 | $26.3M9 | $26.3M3 | $29.2M3 | $24.5M3 |
| Gross profit | $7.1M5 | $7.4M6 | $6.6M7 | $6.5M8 | $5.0M9 | $5.6M3 | $7.1M3 | $2.5M3 |
| Research and development | $528.3K5 | $463.9K6 | $410.5K7 | $472.1K8 | $459.5K9 | $595.2K3 | $571.5K3 | $260.4K3 |
| Selling, general and admin | $8.8M5 | $9.3M6 | $8.6M7 | $8.4M8 | $7.8M9 | $8.6M3 | $7.6M3 | $7.1M3 |
| Operating income | -$1.7M5 | -$1.9M6 | -$2.1M7 | -$2.0M8 | -$2.8M9 | -$3.1M3 | -$526.8K3 | -$4.6M3 |
| Interest | $012 | $06 | $07 | $23.6K8 | $56.2K9 | $64.7K3 | $116.0K3 | $191.4K3 |
| Income before tax | -$4.8M3 | |||||||
| Income tax | $16.6K5 | $301.4K6 | $36.5K7 | $173.0K8 | $29.4K9 | -$130.4K3 | $72.5K3 | $599.7K3 |
| Net income | -$1.8M5 | -$2.3M6 | -$2.1M7 | -$2.2M8 | -$2.1M9 | -$3.0M3 | $1.7M3 | -$5.4M3 |
| Earnings per share | -$0.445 | -$0.576 | -$0.527 | -$0.558 | -$0.539 | -$0.753 | $0.423 | -$1.343 |
| Earnings per share (diluted) | -$0.445 | -$0.576 | -$0.527 | -$0.558 | -$0.539 | -$0.753 | $0.423 | -$1.343 |
| Shares (weighted, basic) | 4.0M shares3 | |||||||
| Shares (weighted, diluted) | 4.0M shares3 |
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Cash | $2.0M6 | $1.7M7 | $995.7K8 | $136.1K9 | $195.5K9 | $2.6M9 | $726.2K3 | $3.3M3 |
| Receivables | $2.4M3 | |||||||
| Inventory | $8.5M3 | |||||||
| Current assets | $15.1M12 | $14.9M5 | $13.2M6 | $12.0M7 | $11.0M8 | $14.9M9 | $13.4M3 | $16.1M3 |
| Property, plant and equipment | $3.4M3 | |||||||
| Total assets | $25.0M12 | $22.5M5 | $19.6M6 | $17.3M7 | $15.5M8 | $19.7M9 | $17.7M3 | $19.7M3 |
| Accounts payable | $1.2M3 | |||||||
| Current liabilities | $4.3M12 | $4.2M5 | $3.5M6 | $3.3M7 | $3.6M8 | $8.9M9 | $7.1M3 | $6.0M3 |
| Long-term debt | $08 | $1.3M9 | $09 | |||||
| Shareholders’ equity | $20.7M6 | $18.3M7 | $16.2M8 | $14.0M9 | $11.9M3 | $8.9M3 | $10.6M3 | $5.2M3 |
| Shares outstanding | 8.0M shares13 | 8.0M shares12 | 4.0M shares5 | 4.0M shares6 | 4.0M shares7 | 4.0M shares8 | 4.0M shares9 | 4.0M shares3 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -$237.0K6 | -$686.9K7 | -$859.6K8 | $59.3K9 | $647.6K3 | -$3.8M3 | -$4.1M3 | |
| Depreciation and amortization | $451.3K3 | |||||||
| Stock-based compensation | $15.6K3 | |||||||
| Capital spending | $141.2K5 | $99.3K6 | $21.0K7 | $08 | $09 | $617.8K3 | $167.2K3 | $75.0K3 |
| Free cash flow | -$336.3K | -$708.0K | -$859.6K | $59.3K | $29.8K | -$4.0M | -$4.2M | |
| Cash from investing | -$75.0K3 | |||||||
| Share buybacks | $013 | |||||||
| Cash from financing | $8.5M3 |
Corporate structure
ALLIED HEALTHCARE PRODUCTS INC sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of ALLIED HEALTHCARE PRODUCTS INC
- John D. Weil Filed SC 13D/A on ALLIED HEALTHCARE PRODUCTS INC, latest Dec 2, 2021 (2 filings since Nov 30, 2021)
- ALLIED HEALTHCARE PRODUCTS INC Saint Louis, Missouri, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What ALLIED HEALTHCARE PRODUCTS INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $33.0M3 Jun 30, 2022 | $33.0M3 Jun 30, 2021 | +0.2% |
| Accumulated depreciation | $29.7M3 Jun 30, 2022 | $29.2M3 Jun 30, 2021 | +1.5% |
| Property and equipment, net | $3.4M3 Jun 30, 2022 | $3.7M3 Jun 30, 2021 | −10.1% |
| Operating-lease assets (leased space) | $8.3K3 Jun 30, 2022 | $13.1K3 Jun 30, 2021 | −36.5% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $3.3M3 Jun 30, 2022 | $726.2K3 Jun 30, 2021 | +356.8% |
Inventory
Leadership
Who has led ALLIED HEALTHCARE PRODUCTS INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerEarl R. Refsland Aug 24, 2009 to Mar 10, 202114
- PresidentEarl R. Refsland Aug 24, 2009 to Mar 10, 202114
- Chief financial officerDaniel C. Dunn Aug 26, 2011 to Aug 26, 201115
Board members and other officers (10)
- Vice President of OperationsKevin D. Kroupa Jul 8, 2021 to Jul 8, 202116
- Vice President of OperationsJoseph F. Ondrus Oct 30, 2020 to Oct 30, 202017
- VP of OperationsAndrew Riley Aug 1, 2014 to Aug 1, 201418
- VP - AdministrationEldon P. Rosentrater Nov 8, 2010 to Aug 26, 201119
- Board memberSusan M. Deuser Jan 3, 2020 to Nov 15, 202120
- Board memberEarl R. Refsland Aug 24, 2009 to Mar 10, 202114
- Board memberJohn D. Weil May 26, 2006 to Nov 30, 202121
- Board memberJoseph Ernest Root Jr. Oct 30, 2006 to Nov 15, 202122
- Board memberJudy T. Graves Nov 20, 2006 to Nov 15, 202123
- Board memberWilliam A. Peck Nov 20, 2006 to Nov 8, 201824
Timeline
- Jul 18, 20238-K Bankruptcy or receivership; Completed an acquisition or sale25
- May 15, 20238-K Results of operations26
- May 12, 20238-K Entered a material agreement; Bankruptcy or receivership; New debt or obligation27
- Mar 16, 20238-K Entered a material agreement; Debt or obligation accelerated; Exit or restructuring costs28
- Feb 27, 20238-K Entered a material agreement; Executive or director change29
- Feb 14, 20238-K Results of operations30
- Feb 8, 20238-K Executive or director change31
- Jan 31, 20238-K Entered a material agreement; Other events32
- Jan 26, 20238-K Exit or restructuring costs; Impairment; Listing notice or transfer33
- Jan 11, 20238-K Other events34
- Dec 22, 20228-K Exit or restructuring costs; Impairment35
- Dec 13, 20228-K Other events36
- Aug 24, 2009New chief executive Earl R. Refsland becomes CEO14
- Dec 19, 1979Founded ALLIED HEALTHCARE PRODUCTS INC is founded2
Calendar
When it reported results
- May 15, 2023Reported quarterly or annual results26
- Feb 14, 2023Reported quarterly or annual results30
- Nov 15, 2022Reported quarterly or annual results37
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
37 filings to the SEC since October 2021: 1 annual reports, 3 quarterly reports, 19 major events, 5 insider forms, 2 large holders, 7 other. The latest 20:
- Jul 18, 20238-K EDGAR
- May 15, 20238-K EDGAR
- May 15, 2023NT 10-Q EDGAR
- May 12, 20238-K EDGAR
- Mar 16, 20238-K EDGAR
- Mar 3, 202325-NSE EDGAR
- Feb 27, 20238-K EDGAR
- Feb 14, 20238-K EDGAR
- Feb 14, 2023NT 10-Q EDGAR
- Feb 8, 20238-K EDGAR
- Jan 31, 20238-K EDGAR
- Jan 26, 20238-K EDGAR
- Jan 11, 20238-K EDGAR
- Dec 22, 20228-K EDGAR
- Dec 13, 20228-K EDGAR
- Nov 28, 20228-K EDGAR
- Nov 15, 20228-K EDGAR
- Nov 14, 2022NT 10-Q EDGAR
- Nov 14, 20228-K EDGAR
- Oct 12, 2022DEF 14A EDGAR
The 37 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
1 open-market trades by officers, directors and large owners since October 2021: 0 buys and 1 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 26, 2021 | WEIL JOHN DDirector | Sale | 135,864 | $8.43 | $1.1M | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- John D. WeilSC 13D/A, 2 filings Nov 30, 2021 to Dec 2, 202138
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- PPP loans $2.4M
Figures by year
| Year | PPP loans | Total |
|---|---|---|
| 2020 | $2.4M | $2.4M |
PPP loans
Paycheck Protection Program loans of $150,000 and up, approved April 2020 to July 2021, from the SBA39. Matched to this company by name and state.
- Apr 13, 2020$2.4M PPP loan (first draw) from First Mid Bank and Trust National Association39To ALLIED HEALTHCARE PRODUCTS INC, St Louis MO; $2.4M forgiven Jun 14, 2021
SEC filer profile
How ALLIED HEALTHCARE PRODUCTS INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARALLIED HEALTHCARE PRODUCTS INC1
- CIK0000874710
- Employer ID (EIN)23-13707211
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inDelaware1
- Fiscal year endsJune 301
- Industry code (SIC)3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies1
- Business address1720 Sublette Ave, St Louis, MO 631101
- Mailing address1720 Sublette Avenue, St Louis, MO 631101
- Phone31477124001
- Shares outstanding4,013,537 as of Sep 14, 20223
- Public float$22.3M as of Dec 31, 20213
- On EDGAR sinceJan 3, 19961
- Filings564 in all: 4 (163), 8-K (95), 10-Q (78), SC 13G/A (67), SC 13D/A (30), 10-K (27), DEF 14A (27), SC 13G (15)1
All 25 form types
ARS (10), 3 (8), SD (7), 10-K/A (6), 4/A (6), SC 13D (4), CORRESP (3), DEFA14A (3), NT 10-Q (3), S-8 (3), UPLOAD (3), 10-Q/A (1), 25-NSE (1), 5 (1), 8-A12G (1), NT 10-K (1), PRE 14A (1)
- Latest filingsAnnual report (10-K) Oct 7, 2022
Quarterly report (10-Q) May 16, 2022
Proxy statement (DEF 14A) Oct 12, 2022
Latest 8-K (8-K) Jul 18, 2023
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18SEC EDGARAndrew Riley, VP of Operations
- 19
- 20SEC EDGARSusan M. Deuser, Board member
- 21SEC EDGARJohn D. Weil, Board member
- 22SEC EDGARJoseph Ernest Root Jr., Board member
- 23SEC EDGARJudy T. Graves, Board member
- 24SEC EDGARWilliam A. Peck, Board member
- 25
- 26SEC EDGARResults of operations
- 27
- 28
- 29
- 30SEC EDGARResults of operations
- 31SEC EDGARExecutive or director change
- 32
- 33
- 34SEC EDGAROther events
- 35
- 36SEC EDGAROther events
- 37
- 38
- 39